Auto Added by WPeMatico
The last time we did comparative tests of AI models from OpenAI and Google at Ars was in late 2023, when Google’s offering was still called Bard. In the roughly two years since, a lot has happened in the world of artificial intelligence. And now that Apple has made the consequential decision to partner with […]
Has Gemini surpassed ChatGPT? We put the AI models to the test. Read More »
AI cost efficiency and data sovereignty are at odds, forcing a rethink of enterprise risk frameworks for global organisations. For over a year, the generative AI narrative focused on a race for capability, often measuring success by parameter counts and flawed benchmark scores. Boardroom conversations, however, are undergoing a necessary correction. While the allure of
Balancing AI cost efficiency with data sovereignty Read More »
For many large companies, artificial intelligence still lives in side projects. Small teams test tools, run pilots, and present results that struggle to spread beyond a few departments. Citi has taken a different path, where instead of keeping AI limited to specialists, the bank has spent the past two years pushing the technology into daily
The quiet work behind Citi’s 4,000-person internal AI rollout Read More »
Scaling AI value from isolated pilots to enterprise-wide adoption remains a primary hurdle for many organisations. While experimentation with generative models has become ubiquitous, industrialising these tools (i.e. wrapping them in necessary governance, security, and integration layers) often stalls. Addressing the gap between investment and operational return, IBM has introduced a new service model designed
Inside large banks, artificial intelligence has moved into a category once reserved for payment systems, data centres, and core risk controls. At JPMorgan Chase, AI is framed as infrastructure the bank believes it cannot afford to neglect. That position came through clearly in recent comments from CEO Jamie Dimon, who defended the bank’s rising technology
JPMorgan Chase treats AI spending as core infrastructure Read More »
Author: Richard Farrell, CIO at Netcall After a year of rapid adoption and high expectations surrounding artificial intelligence, 2026 is shaping up to be the year CIOs apply a more strategic lens. Not to slow progress, but to steer it in a smarter direction. In 2025, we saw the rise of AI copilots across almost
AI dominated the conversation in 2025, CIOs shift gears in 2026 Read More »
The ETSI EN 304 223 standard introduces baseline security requirements for AI that enterprises must integrate into governance frameworks. As organisations embed machine learning into their core operations, this European Standard (EN) establishes concrete provisions for securing AI models and systems. It stands as the first globally applicable European Standard for AI cybersecurity, having secured
Hiring at large firms has long relied on interviews, tests, and human judgment. That process is starting to shift. McKinsey has begun using an AI chatbot as part of its graduate recruitment process, signalling a shift in how professional services organisations evaluate early-career candidates. The chatbot is being used during the initial stages of recruitment,
McKinsey tests AI chatbot in early stages of graduate recruitment Read More »
OpenAI, Google, and Anthropic announced specialised medical AI capabilities within days of each other this month, a clustering that suggests competitive pressure rather than coincidental timing. Yet none of the releases are cleared as medical devices, approved for clinical use, or available for direct patient diagnosis—despite marketing language emphasising healthcare transformation. OpenAI introduced ChatGPT Health on January
Drug development is producing more data than ever, and large pharmaceutical companies like AstraZeneca are turning to AI to make sense of it. The challenge is no longer whether AI can help, but how tightly it needs to be built into research and clinical work to improve decisions around trials and treatment. That question helps
AstraZeneca bets on in-house AI to speed up oncology research Read More »
